Bio-Rad Laboratories, Inc. (BIO) Balance Sheet

The balance sheet shows a stable core, with total liabilities hovering around $3B and equity consistently above $6.6B. The sharp drop in assets and equity in 2024Q1 to 2024Q2 likely mirrors the mark-to-market of the Sartorius stake, as seen in prior income statement volatility. This suggests the balance sheet's headline numbers are heavily influenced by non-operating investment valuations, masking the underlying stability of the operating business.

Debt levels have been remarkably stable, hovering around $1.4B, while equity has grown from $6.6B to $7.2B, keeping D/E low. This suggests the company is not aggressively leveraging, and the debt is likely manageable relative to cash flows. The stable debt and low leverage imply that refinancing risk is minimal, and the company has capacity to support its operations without straining its balance sheet.

The jump in goodwill in 2025Q1 suggests an acquisition, which may have contributed to the company's growth strategy. Meanwhile, net PPE has been gradually declining, from $740M in 2025Q2 to $672M in 2026Q2, indicating that capital expenditures are not keeping pace with depreciation, consistent with a maintenance-heavy capex profile. This asset mix suggests a business that is becoming more asset-light in its operations but is adding intangible value through acquisitions.

Retained earnings have increased steadily, from $7.4B in 2024Q4 to $8.0B in 2026Q2, even as net income swung wildly due to investment gains and losses. This indicates that the core business is generating profits that are being reinvested, and the equity base is solid. The stability in retained earnings, despite the investment volatility, suggests that the company's operational profitability is the primary driver of equity growth, which is a positive sign for shareholders.

The current ratio has been consistently above 3, reaching as high as 6.57 in 2024Q1, indicating strong liquidity. Cash balances have remained around $400-500M, which, combined with the high current ratio, suggests the company has ample liquidity to cover its short-term liabilities and fund operations. This strong liquidity position provides a cushion against market shocks and supports the company's ability to invest in growth opportunities.